Animals (Sep 2021)

Evaluation of the Safety and Feasibility of Apheresis in Dogs: For Application in Metastatic Cancer Research

  • Haru Yamamoto,
  • Mohamed Elbadawy,
  • Koudai Fujisaka,
  • Yomogi Sato,
  • Takahiro Ohmori,
  • Yuta Shinohara,
  • Yui Hatano,
  • Daichi Kobayashi,
  • Ayana Gomyo,
  • Yuji Sudo,
  • Daigo Azakami,
  • Tsuyoshi Uchide,
  • Ryuji Fukushima,
  • Shohei Morita,
  • Amira Abugomaa,
  • Hideyuki Yamawaki,
  • Masahiro Kaneda,
  • Tatsuya Usui,
  • Kazuaki Sasaki

DOI
https://doi.org/10.3390/ani11102770
Journal volume & issue
Vol. 11, no. 10
p. 2770

Abstract

Read online

In patients with solid tumors, circulating tumor cells (CTCs) spread in their blood and function as a seed for metastases. However, the study of CTCs has been limited by their rarity, low frequency, and heterogeneity. The efficient collection of CTCs will contribute to further research of metastatic cancers. Apheresis is a process in which the whole blood of an individual is passed through a machine that isolates a particular constituent and returns the remainder to the circulation. In the present study, we investigated the safety and feasibility of apheresis to separate peripheral blood monocytes (PBMCs), whose density is closely similar to that of CTCs, and to capture intravenously administered human breast cancer cells, MCF7s, from the dogs. No life-threatening events were observed in dogs during the apheresis process. The changes in the hemogram were transient and recovered gradually within a few days after apheresis. During apheresis, 50 mL of PBMCs could be collected from each dog. Notably, a thrombus was formed along the circuit wall during apheresis, which decreased the blood collection pressure. MCF7 cells were successfully captured by the apheresis machine. The captured cells were regrown in vitro and characterized compared with the original cells. In conclusion, apheresis could be safely performed in dogs to isolate CTCs with precautions to maintain hemodynamic stability.

Keywords